Petitions for Reconsideration and Clarification of Action in Rulemaking Proceeding, 1252 [05-259]
Download as PDF
1252
Federal Register / Vol. 70, No. 4 / Thursday, January 6, 2005 / Notices
Environmental protection, Pesticides
and pest.
Dated: December 23, 2004.
Jack E. Housenger,
Acting Director, Antimicrobials Division,
Office of Pesticide Programs.
[FR Doc. 05–260 Filed 1–5–05; 8:45 am]
BILLING CODE 6560–50–S
Internal personnel rules and procedures
or matters affecting a particular
employee.
FOR FURTHER INFORMATION CONTACT: Mr.
Robert Biersack, Press Officer,
Telephone: (202) 694–1220.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Darlene Harris,
Deputy Secretary of the Commission.
[FR Doc. 05–377 Filed 1–4–05; 2:33 pm]
List of Subjects
Dated: December 30, 2004.
B. Kathy Skipper,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–271 Filed 1–5–05; 8:45 am]
BILLING CODE 6715–01–M
FEDERAL COMMUNICATIONS
COMMISSION
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Report No. 2684]
Petitions for Reconsideration and
Clarification of Action in Rulemaking
Proceeding
December 1, 2004.
Petitions for Reconsideration and
Clarification have been filed in the
Commission’s Rulemaking proceeding
listed in this Public Notice and
published pursuant to 47 CFR Section
1.429(e). The full text of this document
is available for viewing and copying in
Room CY–B402, 445 12th Street, SW.,
Washington, DC or may be purchased
from the Commission’s copy contractor,
Best Copy and Printing, Inc. (BCPI) (1–
800–378–3160). Oppositions to these
petitions must be filed by January 21,
2005. See Section 1.4(b)(1) of the
Commission’s rules (47 CFR 1.4(b)(1)).
Replies to an opposition must be filed
within 10 days after the time for filing
oppositions have expired.
Subject: In the Matter of Second
Periodic Review of the Commission’s
Rules and Policies Affecting the
Conversion to Digital Television (MB
Docket No. 03–15).
Number of Petitions Filed: 11.
Marlene H. Dortch,
Secretary.
[FR Doc. 05–259 Filed 1–5–05; 8:45 am]
BILLING CODE 6712–01–M
FEDERAL ELECTION COMMISSION
Sunshine Act Notices
Tuesday, January 11,
2005 at 10 a.m.
PLACE: 999 E Street, NW., Washington,
DC.
STATUS: This meeting will be closed to
the public.
Compliance matters pursuant to 2
U.S.C. § 437g.
Audits conducted pursuant to 2 U.S.C.
§ 437g, § 438(b), and Title 26, U.S.C.
Matters concerning participation in civil
actions or proceedings or arbitration.
DATE AND TIME:
VerDate jul<14>2003
15:45 Jan 05, 2005
Jkt 205001
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee on Childhood
Lead Poisoning Prevention (ACCLPP):
Meeting
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the National Center for
Environmental Health (NCEH) of the
Centers for Disease Control and
Prevention (CDC) announces the
following committee meeting.
Name: Advisory Committee on Childhood
Lead Poisoning Prevention.
Times and Dates: 8:30 a.m.–5 p.m., March
22, 2005; 8:30 a.m.–12:30 p.m., March 23,
2005.
Place: Sheraton New Orleans Hotel, 500
Canal Street, New Orleans, LA 70130,
Telephone: (504) 595–6211 or toll free 1–
888–627–7033.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people.
Purpose: The Committee provides advice
and guidance to the Secretary; the Assistant
Secretary for Health; and the Director, CDC,
regarding new scientific knowledge and
technological developments and their
practical implications for childhood lead
poisoning prevention efforts. The committee
also reviews and reports regularly on
childhood lead poisoning prevention
practices and recommends improvements in
national childhood lead poisoning
prevention efforts.
Matters To Be Discussed: Update on the
Lead and Pregnancy Workgroup Agenda
activities, ACCLPP process for work group
projects, updates of the clinical and public
health implications of adverse health effects
of blood lead levels less than 10 µg/dL.
Agenda items are subject to change as
priorities dictate.
Opportunities will be provided during the
meeting for oral comments. Depending on the
time available and the number of requests, it
may be necessary to limit the time of each
presenter.
For Further Information Contact: Crystal
M. Gresham, Program Analyst, Lead
Poisoning Prevention Branch, Division of
Emergency and Environmental Health
Services, NCEH, CDC, 4770 Buford Hwy, NE.,
M/S F–40, Atlanta, Georgia 30341, telephone
(770) 488–7490, fax (770) 488–3635.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Publication of closed meeting
summary of the Advisory Board on
Radiation and Worker Health (ABRWH),
National Institute for Occupational
Safety and Health (NIOSH).
ACTION:
Committee Purpose: This board is
charged with (a) providing advice to the
Secretary, HHS on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS on the scientific validity
and quality of dose reconstruction
efforts performed for this Program; and
(c) upon request by the Secretary, HHS,
advise the Secretary on whether there is
a class of employees at any Department
of Energy facility who were exposed to
radiation but for whom it is not feasible
to estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class.
Background: The Advisory Board on
Radiation and Worker Health met on
December 13, 2004, in closed session to
discuss Individual Case Dose
Reconstruction Reviews. The discussion
involved individual dose reconstruction
case reviews. The individual cases the
ABRWH discussed included personal
information of a confidential nature
where disclosure would constitute a
clearly unwarranted invasion of
personal privacy and, therefore, could
not be disclosed. A Determination to
Close the meeting was approved and
published, as required by the Federal
Advisory Committee Act.
Summary of the Meeting: Attendance
was as follows:
Board Members:
Paul L. Ziemer, Ph.D., Chair.
Lew Wade, Ph.D., Executive Secretary
(Pro Tem).
Antonio Andrade, Ph.D., Member.
Roy L. DeHart, M.D., M.P.H., Member.
E:\FR\FM\06JAN1.SGM
06JAN1
Agencies
[Federal Register Volume 70, Number 4 (Thursday, January 6, 2005)]
[Notices]
[Page 1252]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-259]
=======================================================================
-----------------------------------------------------------------------
FEDERAL COMMUNICATIONS COMMISSION
[Report No. 2684]
Petitions for Reconsideration and Clarification of Action in
Rulemaking Proceeding
December 1, 2004.
Petitions for Reconsideration and Clarification have been filed in
the Commission's Rulemaking proceeding listed in this Public Notice and
published pursuant to 47 CFR Section 1.429(e). The full text of this
document is available for viewing and copying in Room CY-B402, 445 12th
Street, SW., Washington, DC or may be purchased from the Commission's
copy contractor, Best Copy and Printing, Inc. (BCPI) (1-800-378-3160).
Oppositions to these petitions must be filed by January 21, 2005. See
Section 1.4(b)(1) of the Commission's rules (47 CFR 1.4(b)(1)). Replies
to an opposition must be filed within 10 days after the time for filing
oppositions have expired.
Subject: In the Matter of Second Periodic Review of the
Commission's Rules and Policies Affecting the Conversion to Digital
Television (MB Docket No. 03-15).
Number of Petitions Filed: 11.
Marlene H. Dortch,
Secretary.
[FR Doc. 05-259 Filed 1-5-05; 8:45 am]
BILLING CODE 6712-01-M